CANCER CHEMOTHERAPY AND PHARMACOLOGY, vol.74, no.4, pp.751-756, 2014 (SCI-Expanded)
The aim of this study was to evaluate efficacy and safety of chronomodulated capecitabine administered according to a specific time schedule (Brunch Regimen: Breakfast and Lunch) as a part of neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer.